Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
1.49%
↑ 116% vs avg
Percentile
P85
Within normal range
Streak
1 qtr
Consecutive growthStable
Average
-9.51%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 1.49% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | -36.36% |
| Q3 2018 | -59.26% |
| Q2 2018 | 160.00% |
| Q1 2018 | 64.57% |
| Q4 2017 | -570.37% |
| Q3 2017 | 114.21% |
| Q2 2017 | 7.77% |
| Q1 2017 | 84.30% |
| Q4 2016 | 3.67% |
| Q3 2016 | -30.46% |
| Q2 2016 | -1.36% |
| Q1 2016 | -2.90% |
| Q4 2015 | -15.72% |